, China
/Freepik

SINOSURE’s exposure to risky assets remains a concern, Fitch says

Capitalisation is expected to remain adequate to support underwriting expansion.

China Export & Credit Insurance Corporation’s (SINOSURE) outlook remains negative amidst policy-oriented role in supporting China's export activities and its government ownership, Fitch Ratings said.

Jointly owned by the Ministry of Finance and Central Huijin Investment Ltd, the company holds a strong position in the export credit insurance market, providing coverage for overseas trade and investment. 

Fitch expects SINOSURE to maintain its nationwide presence and its role in stabilising foreign trade.  

Capitalisation is expected to remain adequate to support underwriting expansion and manage risk. 

Investment returns remain the key driver of earnings, with higher investment income and reduced unrealised foreign currency losses contributing to improved profits in 2023.

However, underwriting earnings are expected to remain marginal due to the company’s policy-oriented mandate. 

SINOSURE continues to follow a conservative investment strategy, with a significant portion of assets held in cash, term deposits, and bonds, whilst exposure to riskier assets was limited to about 27% of its equity capital at the end of 2023.
 

Follow the link s for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.